Farms.com Home   News

Climate Change Could Increase Crop Insurance Losses

Climate change could increase losses in flood and crop insurance programs significantly in coming decades, according to a USA Today article available here. Agri-Pulse also published an article available here and Insurance News here.

The Government Accountability Office’s (GAO) report found that exposure to losses for property insured under the two programs grew from 8 percent to $1.4 trillion over the past six years due to population growth and increased property values in hazard-prone areas.

The GAO study says climate change “may substantially increase losses by 2040 and increases losses from about 50 to 100 percent by 2100,” according to Agri-Pulse.

“(FEMA and RMA) face challenges that may limit their ability to minimize long-term federal exposure to climate change,” the report summary said. “For example, because of the short-term nature of insurance (i.e., contracts typically estimate and communicate risk of property losses for the 1-year term of a policy), FEMA and RMA face a challenge in encouraging policyholders to reduce their long-term exposure to climate change risks.”

FEMA is currently $24 billion in debt because of extreme weather events, and in 2006 the GAO labeled the National Flood Insurance Program as "high risk" for long-term insolvency, according to Insurance News.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.